Today is sure to be a bumpy day on Wall Street with the last economic numbers giving most investors a reason to press pause on their strategy and look on. Lessened trading equals more volatility. Until the next set of economic numbers is released next week, It would be shocking to see a ton of positive movement on this Friday afternoon. To review, here are three small cap market movers buzzing on everyone’s radar.

Chelsea Therapeutics, CHTP announced yesterday that their phase 2 clinicial study of Droxidopa has been initiated into a chronic fatigue syndrome study. 20 patients have been enrolled in the program and will be monitored for 12 weeks. Further studies will be used upon completion of the three month trial. These phase trials make or break bio companies and often has the company’s stock trading very volatile. Most of these small cap biotech companies are in an aggressive portfolio manager’s line up. Throwing a dart every now and then in the hope of FDA approval can be lucky break. In the company’s last conference call on June 27th, the company reported a net loss for the second quarter of $9.9 million or $.25 a share, which can be expected from a company looking for approval. The metric to look at here is product development and R&D, the most far along being a Phase three study of Northera Study 301. Second on today’s watch list is Mentor Graphics, symbol MENT which is trading at $9.75 up $.73 or 8% on a volume of over 500k. The company soared this morning after reporting earnings for the second quarter yesterday at the market close. The company reported $187.9 million in revenue along with a non GAAP earnings per share of $.01 and a GAAP loss per share of $.13. The company has made a few acquisitions recently, including Flomerics, Logic Vision and Valor which are all said to be tracking very well. Guidance for the third quarter includes $220 million in revenue and a non-GAP EPS of $.15, and a GAAP EPS of $.08. For the full year, revenues of $880 million and an EPS of $.20 were estimated. The heightened forecast and encouragement concerning the performance of acquisitions has investors buying. With a Patent Infringement suit against EVE, investors may be confident in the win there as well.

For more information visit http://www.worldmarketmedia.com/779/section.aspx/2270/post/three-small-cap-market-movers-nasdaq-chtp-ment-amex-pip - About the Author: WorldMarketMedia.com (The Global Online Investment Community) is a high traffic stock market, news data website providing cutting edge new media products and services to publicly traded companies worldwide. Our Editor’s Desk authors insightful real-time coverage on the economy, the capital markets and their listed companies. Article Source